右美托咪定在行腔镜妇科手术后恶心呕吐患者中的应用

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the application of Dexmedetomidine in patients with nausea and vomiting after endoscopic gynecological surgery. Methods From January 2019 to January 2021, a total of 66 patients underwent laparoscopic gynecological surgery at Guangzhou Panyu District He Xian Memorial Hospital and who developed nausea and vomiting after the operation were selected as the research objects, and they were divided into the study groups and the control group according to the drawing lots method, with 33 cases in each. The control group used Sufentanil 150 μg,and the study group used Sufentanil 150 μg + Dexmedetomidine 200 μg. And set the lock time, infusion rate and single load dose to 15 min, 2 ml/h, 2 ml in sequence. The intraoperative Opioid dosage, pneumoperitoneum pressure and time,and total gas consumption were compared between the two groups of patients. At the same time, the nausea and vomiting, sedation scores of the two groups of patients at different time periods were observed. Results There were no statistically significant differences of intraoperative Opioid dosage, pneumoperitoneum pressure and time, and total gas consumption between the two groups (P＞0.05). At six to below twelve hours, twelve to below eighteen hours, eighteen to below twenty-four hours after surgery,the nausea and vomiting score of the study groups were higher than those of the control group,and the differences were statistically significant (P＜0.05).At below six hours,six to below twelve hours,twelve to below eighteen hours, eighteen to below twenty-four hours after surgery, the sedation score of the study groups were lower than those of the control group, and the differences were statistically significant (P＜0.05). Conclusion The improperness mirror and gynecologic surgery in patients with postoperative nausea and vomiting condition, application of self-control vein analgesia pump, scientific administration of Dexmetomidine drugs is better than the simple application of Sulfentanyl, could keep calm and able to help patients, and the effect is remarkable, it is worth promoting.

Key words： Dexmedetomidine Mitigation Laparoscope Gynecological surgery Nausea and vomiting

Received: 20 April 2021

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I35/168

[1]	刘振菁，陈易，邢学宁，等.右美托咪定用于妇科腹腔镜术后镇痛预防恶心呕吐的适宜剂量[J].中华麻醉学杂志，2019，39（9）：1095-1098.
[2]	曹为民，范俊峰，陶阳，等.腹横肌平面阻滞联合右美托咪定对妇科患者腹腔镜术后恢复的影响[J].现代仪器与医疗，2018，24（3）：132-134.
[3]	李禾南，李想，赵静宜，等.盐酸右美托咪定应用于妇科腹腔镜手术不同时间点对患者术后临床疗效的影响[J].中国临床医生杂志，2020，48（6）：740-743.
[4]	徐保芹，王洁，张超，等.右美托咪定对妇科腹腔镜手术患者血浆胃动素及术后不良反应的影响[J].医学研究生学报，2019，32（5）：84-89.
[5]	Ramsay M，Savege T，Simpson B，et al.Controlled sedation with alphaxolone-alphadalone[J].Br Med J，1974，2（5920）：656-659.
[6]	邢曼玉，梁霞，郭曲练，等.右美托咪定联合局麻药腹腔滴注缓解腹腔镜手术术后疼痛的Meta 分析[J].临床麻醉学杂志，2020，36（4）：364-370.
[7]	杨艳超，邱延伟，曹晓玮.右美托咪定应用于术后镇痛对腹腔镜子宫肌瘤剥除术患者氧化应激以及舒适性的影响[J].现代中西医结合杂志，2020，29（32）：94-97.
[8]	刘先保，张春芳，陈涛，等.右美托咪定联合舒芬太尼对剖宫产术后镇痛效果影响[J].临床医学工程，2015，22（3）：296-297.
[9]	邓敏佳，胡丽辉，黄笑芳，等.局麻药联合右美托咪定腹腔注射对腹腔镜手术后镇痛效果影响的系统评价[J].中国医药导报，2020，540（10）：119-123.
[10]	袁振武，郭小丽，肖迪，等.右美托咪定鼻内滴注对妇科腹腔镜全麻患者拔管反应和术后寒战的影响[J].临床麻醉学杂志，2020，36（3）：244-248.
[11]	许丽满.Ramsay 镇静评分法在对重症监护病房的患儿进行镇静治疗中的应用效果[J].当代医药论丛，2018，16（19）：220-221.
[12]	邱壮光，徐志新，韦雪梅，等.子宫切除术后右美托咪定联合舒芬太尼术后镇痛对患者睡眠质量的影响[J].临床药物治疗杂志，2019，17（8）：55-58，83.
[13]	卢志方，郭斌，董补怀，等.单纯全身麻醉与复合硬膜外应用右美托咪定和吗啡麻醉203 例对比研究[J].陕西医学杂志，2020，541（7）：92-95.
[14]	司海超，司小萌，张新科，等.盐酸右美托咪定对肺癌患者术后镇痛效果及机体免疫功能的影响[J].癌症进展，2019，17（7）：808-811.
[15]	罗瑞敏，尧永华.应重视右美托咪定在化疗相关性恶心呕吐中的应用[J].实用医学杂志，2020，36（6）：707-710.